Pediatric-Type Therapy Including Lineage-Targeted Methotrexate to Improve Early Minimal Residual Disease Response and Survival In Adult Acute Lymphoblastic Leukemia (ALL): Interim Analysis of Northern Italy Leukemia Group Study 10/07
Renato Bassan(Pittini Group (Italy)), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Elena Oldani(Ospedale Papa Giovanni XXIII), Fabio Ciceri(Vita-Salute San Raffaele University), Erika Borlenghi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Vincenzo Cassibba, Arianna Masciulli(Ospedale Papa Giovanni XXIII), Claudio Romani(Azienda Ospedaliera G. Brotzu), Barbara Peruta(Ospedale Papa Giovanni XXIII), Federica Delaini(Ospedale Papa Giovanni XXIII), Tamara Intermesoli(University of Bergamo), Alessandro Levis(San Antonio College), Margherita Parolini(Ospedale Papa Giovanni XXIII), Giorgio Lambertenghi‐Deliliers(Ospedale Maggiore), Giuseppe Rossi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Ernesta Audisio(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Monica Fumagalli(Azienda Ospedaliera San Gerardo), Enrico Maria Pogliani(Azienda Ospedaliera San Gerardo), Roberto Marchioli, Rosa Maria Marfisi(Mario Negri Sud Foundation), Manuela Tosi(Ospedale Papa Giovanni XXIII), Daniele Mattei, Eros Di Bona(San Antonio College), Orietta Spinelli(Ospedale Papa Giovanni XXIII)
Cited by 2
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
|JAMA|2005|1.1k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k